IMDZ

Immune Design Corp. - Common Stock

$3.69 +$0.04 +1.22%


Own 3 of IMDZ at $3.85 which is 0.02% of the portfolio.

-$0.16 (-4.03%)

Shares Bought3
Shares Sold0
Total3
Shares Owned3
Last Price$3.69
Total Return-$0.46
Range Today$3.55 - $3.73
52 Week Range$3.50 - $13.05
Open$3.65
Market Cap$94.85M
Volume/Average242.57K/350.59K
P/E Ratio-
Dividend/Yield-




Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Seattle, WA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
17-12-18 18:53 $3.85 $3.69 -$0.15 -3.90% ad3nine
17-12-18 18:54 $3.85 $3.69 -$0.15 -3.90% ad3nine
17-12-18 18:50 $3.85 $3.69 -$0.16 -4.03% ad3nine

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners